HIV-1 variants from a perinatal transmission pair demonstrate similar genetic and replicative properties in tonsillar tissues and peripheral blood mononuclear cells

AIDS Research and Human Retroviruses

Volumn 23, Issue 9, 2007, Pages 1095-1104

  Gray, Laurie ^a   Fiscus, Susan ^b   Shugars, Diane ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; VIRUS RNA;

ARTICLE; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; OROPHARYNX; PALATINE TONSIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYNCYTIUM; TONSIL; VERTICAL TRANSMISSION; VIRUS ISOLATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL LINE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HETERODUPLEX ANALYSIS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINATION, GENETIC; TONSIL; VARIATION (GENETICS); VIRUS REPLICATION;

EID: 35348853961     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0247     Document Type: Article

References (49)

1. Mofenson LM, Committee on Pediatric AIDS: Technical report: Perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics 2000;106:E88. Available at http://www.pediatrics.org/cgi/content/full/106/6/e88 (accessed July 2007).
2. Dunn DT, Newell ML, Ades AE, and Peckham CS: Risk of human immunodeficiency virus type 1 transmission through breast-feeding. Lancet 1992;340:585-588.
3. Lewis P, Nduati R, Kreiss JK, et al.: Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 1998;177:34-39.
4. Van de Perre P, Simonon A, Hitimana DG, et al.: Infective and anti-infective properties of breast milk from HIV-1-infected women. Lancet 1993;341:914-918.
5. Nduati RW, John GC, Richardson BA, et al.: Human immunodeficiency virus type 1-infected cells in breast milk: Association with immunosuppression and vitamin A deficiency. J Infect Dis 1995;172:1461-148
6. Thiry L, Sprecher-Goldberger S, Jonckheer T, et al.: Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985;2:891-892.
7. Miotti PG, Taha TE, Kumwenda NI, et al.: HIV transmission through breastfeeding: A study in Malawi. JAMA 1999;282:744-749.
8. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004;35:196-202.
9. Koulinska IN, Villamor E, Chaplin B, et al.: Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr 2006;41:93-99.
10. Amedee AM, Rychert J, Lacour N, Fresh L, and Ratterree M: Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology 2004;1:17.
11. Kourtis AP, Butera S, Ibegbu C, Belec L, and Duerr A: Breast milk and HIV-1: Vector of transmission or vehicle of protection? Lancet Infect Dis 2003;3:786-793.
12. Rousseau CM, Nduati RW, Richardson BA, et al.: Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 2004;190:1880-1888.
13. Becquart P, Chomont N, Roques P, et al.: Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 2002;300:109-117.
14. Henderson GJ, Hoffman NG, Ping LH, et al.: HIV-1 populations in blood and breast milk are similar. Virology 2004;330:295-303.
15. Glushakova S, Baibakov B, Margolis LB, and Zimmerberg J: Infection of human tonsil histocultures: A model for HIV pathogenesis. Nat Med 1995;1:1320-1322.
16. Margolis LB, Glushakova S, Baibakov B, and Zimmerberg J: Syncytium formation in cultured human lymphoid tissue: Fusion of implanted HIV glycoprotein 120/41-expressing cells with native CD4+ cells. AIDS Res Hum Retroviruses 1995;11:697-704.
17. Glushakova S, Baibakov B, Zimmerberg J, and Margolis LB: Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Hum Retroviruses 1997;13:461-471.
18. Glushakova S, Yi Y, Grivel JC, et al.: Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. J Clin Invest 1999;104:R7-R11.
19. Grivel JC, and Margolis LB: CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999;5:344-346.
20. + T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci USA 1999;96:663-668.
21. +-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 2002;76:1004-1014.
22. Mahler D, Wu X, Shacker T, Larson M, and Southern P: A model system of oral HIV exposure using human palatine tonsil, reveals extensive binding of HIV infectivity, with limited progression to primary infection. J Infect Dis 2004;190:1989-1997.
23. Freel SA, Fiscus SA, Pilcher CD, et al.: Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. AIDS 2003;17:2025-2033.
24. Kitrinos KM, Hoffman NG, Nelson, JAE, and Swanstrom R: Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J Virol 2003;77:6811-6822.
25. Nelson JAE, Fiscus SA, and Swanstrom R: Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol 1997;71:8750-8758.
26. Ping LH, Nelson JA, Hoffman IF, et al.: Characterization of V3 sequence heterogeneity in subtype C human Imunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants. J Virol 1999;73:6271-6281.
27. Trouplin V, Salvatori F, Cappello F, et al.: Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol 2001;75:251-259.
28. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
29. Vodicka MA, Goh WC, Wu LI, et al.: Indicator cell lines for detection of primary strains for human and simian immunodeficiency viruses. Virology 1997;233:193-198.
30. Harrington RD, and Geballe AP: Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol 1993;67:5939-5947.
31. Hu QX, Barry AP, Wang ZX, Connolly SM, Peiper SC, and Greenberg ML: Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis. J Virol 2000;74:11858-11872.
32. Koot M, Vos AH, Keet RP, et al.: HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 co-cultivation assay. AIDS 1992;6:49-54.
33. Goff S, Traktman P, and Baltimore D: Isolation properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J Virol 1981;38:239-248.
34. Ritola K, Pilcher CD, Fiscus SA, et al.: Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol 2004;78:11208-1118.
35. Quinones-Mateu ME, Ball SC, Marozsan AJ, et al.: A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol 2000;74:9222-9233.
36. Ping LH, Cohen MS, Hoffman I, et al.: Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000;74:8946-8952.
37. Hengel RL, Kennedy MS, Steketee RW, Thea DM, Abrams EJ, Lambert G, and McDougal JS: Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS Res Hum Retroviruses 1998;14:475-481.
38. Contag CH, Ehrnst A, Duda J, et al.: Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J Virol 1997;71:1292-1300.
39. Vaillancourt M, Irlbeck D, Smith T, Coombs RW, and Swanstrom R: The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance. AIDS Res Hum Retroviruses 1999;15:355-363.
40. Watkins T, Resch W, Irlbeck D, and Swanstrom R: Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 2003;47:759-769.
41. Kitrinos KM, Nelson JAE, Resch W, and Swanstrom R: Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations. J. Virol 2005;79:10627-10637.
42. Wolinsky SM, Wike CM, Korber BTM, et al.: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-1137.
43. Wike CM, Korber BTM, Daniels MR, et al.: HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses 1992;8:1297-1300.
44. Ahmad N, Baroudy BM, Baker RC, and Chappey C: Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995;69:1001-1012.
45. Lamers SL, Sleasman JW, She JX, et al.: Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants by vertical transmission. J Clin Invest 1994;93:380-390.
46. Kampinga GA, Simonon A, Van de Perre, Karita E, Msellati P, and Goudsmit J: Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997;227:63-76.
47. Derdeyn CA, Decker JM, Bibollet-Ruche F, et al.: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004;303:2019-2022.
48. Chohan B, Lang D, Sagar M, et al.: Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J Virol 2005;79:6528-6531.
49. Meissner EG, Coffield VM, and Su L: Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry. Virology 2005;336:184-197.